Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichi Wada

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Human Immunology|June 15, 2014
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis CTakeji Umemura, Masao Ota, Yoshihiko Katsuyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2018
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study GroupTakehiro Akahane, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Viral Hepatitis|July 26, 2018
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antiviralsAyumi Sugiura, Satoru Joshita, Takeji Umemura, et al.
Cancers|June 2, 2021
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter StudyKaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, et al.
Biomedicines|April 9, 2020
Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment CasesAyumi Sugiura, Satoru Joshita, Yuki Yamashita, et al.
Genome Research|June 20, 2008
The amphioxus genome illuminates vertebrate origins and cephalochordate biologyLinda Z Holland, Ricard Albalat, Kaoru Azumi, et al.
Science (New York, N.Y.)|December 14, 2002
The draft genome of Ciona intestinalis: insights into chordate and vertebrate originsParamvir Dehal, Yutaka Satou, Robert K Campbell, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Human Immunology|June 15, 2014
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis CTakeji Umemura, Masao Ota, Yoshihiko Katsuyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2018
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study GroupTakehiro Akahane, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Viral Hepatitis|July 26, 2018
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antiviralsAyumi Sugiura, Satoru Joshita, Takeji Umemura, et al.
Cancers|June 2, 2021
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter StudyKaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, et al.
Biomedicines|April 9, 2020
Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment CasesAyumi Sugiura, Satoru Joshita, Yuki Yamashita, et al.
Genome Research|June 20, 2008
The amphioxus genome illuminates vertebrate origins and cephalochordate biologyLinda Z Holland, Ricard Albalat, Kaoru Azumi, et al.
Science (New York, N.Y.)|December 14, 2002
The draft genome of Ciona intestinalis: insights into chordate and vertebrate originsParamvir Dehal, Yutaka Satou, Robert K Campbell, et al.
Pageof 5